Abstract:Background: The cell cycle gene centromere protein K (CENPK) is upregulated in various cancers; however, the clinical value and mechanism of CENPK in prostate cancer (PCa) and castration-resistant prostate cancer (CRPC) remain unclear.Methods: The expression of CENPK in PCa was analyzed in both patients with PCa and cell lines using immunohistochemistry (IHC), real-time quantitative reverse transcription PCR (qRT-PCR), Western blot and bioinformatics analyses. Knockdown of CENPK in PCa cells was achieved by transfecting siRNAs and assessed using qRT-PCR and Western blotting. MTT and colony formation assays were used to assess the growth of PCa cells. The cell cycle was analyzed using propidium iodide (PI) staining and flow cytometry. To study the possible biological function of CENPK, pathway enrichment analysis was performed by dividing these groups into a high CENPK expression group and a low CENPK expression group based on the median CENPK expression level. Finally, the correlation between CENPK expression in PCa and clinical parameters was evaluated.Results: Our study revealed that CENPK was expressed at high levels in CRPC tissues and cell lines compared to primary PCa. The downregulation of CENPK significantly inhibited cell viability and reduced the number of colonies formed by LNCaP-AI and DU145 cells (two CRPC cell lines). Gene enrichment and flow cytometry analyses showed that high CENPK expression was linked to mitotic spindles and the cell cycle and may be involved in mitosis in the cell cycle of cancer cells to modulate cell proliferation and promote the development of CRPC. Moreover, patients exhibiting higher expression of the CENPK mRNA experienced shorter disease-free survival (DFS) and overall survival (OS) than the lower expression group.Conclusions: This study provides novel molecular insights into the role of CENPK in castration-resistant PCa cells and reveals that an increase in CENPK expression may indicate shorter DFS and a poor prognosis for patients with PCa. Targeting CENPK may be a novel strategy for the treatment of PCa.

PRKAR2B Plays an Oncogenic Role in the Castration-Resistant Prostate Cancer

CRABP2 Promotes Cell Migration and Invasion by Activating PI3K/AKT and MAPK Signalling Pathways Via Upregulating LAMB3 in Prostate Cancer

Identification of PTPRR and JAG1 as key genes in castration-resistant prostate cancer by integrated bioinformatics methods

Prkar2b Promotes Prostate Cancer Metastasis By Activating Wnt/-Catenin And Inducing Epithelial-Mesenchymal Transition

USP54 is a potential therapeutic target in castration-resistant prostate cancer

Human Kallikrein 2 (KLK2) Promotes Prostate Cancer Cell Growth Via Function As a Modulator to Promote the ARA70-enhanced Androgen Receptor Transactivation.

Transcriptional Regulation of PRKAR2B by Mir-200B-3p/200c-3p and XBP1 in Human Prostate Cancer.

Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis

CRABP2 promotes cell migration and invasion by activating PI3K/AKT and MAPK signaling pathways via up-regulating LAMB3 in prostate cancer

Genome-wide Expression Analysis Identifies the Association between SEC14L2 and Castration-resistant Prostate Cancer Survival

[Role of PRNCR1 in the Castration Resistant Prostate Cancer].

Lipocalin 2 Over-Expression Facilitates Progress of Castration-Resistant Prostate Cancer Via Improving Androgen Receptor Transcriptional Activity

Castration-resistant prostate cancer is resensitized to androgen deprivation by autophagy-dependent apoptosis induced by blocking SKP2

BCAR4 activates GLI2 signaling in prostate cancer to contribute to castration resistance

Targeting Feedforward Loops Formed by Nuclear Receptor RORγ and Kinase PBK in Mcrpc with Hyperactive AR Signaling

Identification of Key Molecules for Castration Resistance Prostate Cancer by Bioinformatic Analysis

Silencing CAPN2 Expression Inhibited Castration-Resistant Prostate Cancer Cells Proliferation and Invasion Via AKT/mTOR Signal Pathway

The cell cycle gene centromere protein K (CENPK) contributes to the malignant progression and prognosis of prostate cancer

Castration-resistant prostate cancer: adaptive responses in the androgen axis.

Data from the Steroid Receptor Coactivator-3 is Required for the Development of Castration-Resistant Prostate Cancer

Advances in the Current Understanding of the Mechanisms Governing the Acquisition of Castration-Resistant Prostate Cancer